Active substance roxadustat
Holder Astellas Pharma B.V.
Status Running
Indication treatment of symptomatic anaemia of Chronic Kidney Disease in non-dialysis and dialysis patients, and where use of available treatment (IV iron or injectable ESAs) is not appropriate or is expected not to be appropriate, or patients who have a known contraindication for the currently available treatment or who do not tolerate the currently available treatment, or are expected not to tolerate this product
Public documents




Information for the patient

Information for the patient-Amendment_1


Informed Consent

Informed consent-Amendment_1

Laast update 28/02/203


Last updated on 27/11/2023